Pharm Wk 14 - Dementia Flashcards
What does cholinesterase inhibitors do?
they block the metabolism of acetylcholine within the synaptic cleft resulting in increased acetylcholine and increased cholinergic transmission
what are the mainstays of treatment for cognitive and function symptoms of most causes of dementia?
cholinesterase inhibitors
While clinically detectable, the benefits of cholinesterase inhibitors for Alzheimer’s disease are?
typically small to moderate
Up to 68% of people with Alzheimer’s disease respond to cholinesterase inhibitors with
an initial period of cognitive stabilization (2–5 months) before continuing to decline at the pretreatment rate
what is the only cholinesterase inhibitor indicated for all disease severities of Alzheimer’s disease and is also used in other neurological diseases that cause dementia
donepezil
what are some adverse effects of donepezil?
diarrhea, nausea, vomiting, anorexia and/or weight loss
what is the mechanism of action of the NMDA receptor antagonist memantine?
to block glutamate-induced neuronal excitotoxicity, a process that is implicated as a final common pathway in neuronal death
memantine is not typically used as ? unless cholinesterase inhibitor therapy is contraindicated or has failed/adverse effects are intolerable
monotherapy
Memnatine is more often used in?
combination with cholinesterase inhibitors to augment the response in severe disease
Responsive behaviours falls within 3 contexts which are:
- due to dementia itself
- due to previous mental health conditions
- due to sudden changes or triggers
what is responsive behaviours?
actions or reactions that people with dementia may show due to changes in their brain or environment
Many patients in the early stages of dementia experience what?
depression
What are less likely than tricyclic antidepressants to cause anticholinergic side effects or to worsen orthostatic hypotension, which are common and problematic in this population
SSRIs (except for paroxetine)
what is generally reserved for the treatment of agitation or psychosis in patients with dementia when symptoms are severe, dangerous, or cause clinically significant distress
antipsychotics
What antipsychotics have the most evidence in this population?
Risperidone and olanzapine